Event Overview
This webinar will explore the relationship between animal pharmaceutical companies and antimicrobial resistance (AMR). Join us to learn more about the current landscape of AMR, how -and if- animal pharmaceutical companies are addressing this issue, and the potential impact on investment opportunities in this space.
Don’t miss this opportunity to gain valuable insights from industry experts and engage with a thought-provoking discussion on this critical topic. We will also be joined by investor guest speakers who will speak on their experiences engaging with animal pharmaceutical companies.
Speakers Include:
Emma Berntman, Senior Engagement Specialist, FAIRR Initiative
Sophie Bartley, ESG Analyst, FAIRR Initiative
We will also be joined by investors Maria Ortino, Senior Global ESG Manager, LGIM, and Alexandra Frenander, ESG Corporate Analyst, Folksam Group, who will speak on their experiences engaging with animal pharmaceutical companies.
Please note that this event is exclusive to FAIRR’s investor members.